François Abel

Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial

Eugenio Mercuri, Francesco Muntoni, Giovanni Baranello et al. · The Lancet Neurology · 2021 · 237 citations

Gene Therapies, Clinical Trials, Neurology +2

The successful use of the nasopharyngeal airway in Pierre Robin sequence: an 11-year experience

François Abel, Yogesh Bajaj, Colin Wallis · Archives of Disease in Childhood · 2012 · 135 citations

ERS statement on paediatric long-term noninvasive respiratory support

Brigitte Fauroux, François Abel, Alessandro Amaddeo et al. · European Respiratory Journal · 2021 · 93 citations · Full text

Palliative Care, Asthma, Continuous Support +11

Cardiorespiratory Progression Over 5 Years and Role of Corticosteroids in Duchenne Muscular Dystrophy

Federica Trucco, Joana Domingos, Chee Geap Tay et al. · CHEST Journal · 2020 · 45 citations

Adrenal Gland, Health Sciences, Skeletal Muscle +8

Obstructive sleep apnoea in craniofacial microsomia: analysis of 755 patients

Cornelia J.J.M. Caron, Britt I. Pluijmers, Britta D. P. J. Maas et al. · International Journal of Oral and Maxillofacial Surgery · 2017 · 43 citations

Obstructive Sleep Apnoea, Sleep, Craniomaxillofacial Trauma Surgery +10